Esperion Therapeutics
ESPR
#6196
Rank
C$1.19 B
Marketcap
C$5.06
Share price
-2.64%
Change (1 day)
52.55%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): C-$0.71

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.69. In 2024 the company made an earnings per share (EPS) of C-$0.32 an increase over its 2023 EPS that were of C-$2.91.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.71124.68%
2024C-$0.32-89.15%
2023C-$2.91-40.28%
2022C-$4.88-62.87%
2021C-$13.1480.38%
2020C-$7.2850.14%
2019C-$4.85-53.18%
2018C-$10.367.41%
2017C-$9.65110.81%
2016C-$4.5847.35%
2015C-$3.110.89%
2014C-$3.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
C-$8.16 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$3.74-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.36-444.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$59.69-8,788.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.26-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA